Indian Temozolomide Exporters: Complete Supplier Ranking with Market Share — 250 Manufacturers (2026) — TransData Nexus

Q: Who is the largest temozolomide buyer importing from India?

YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the largest temozolomide importer from India with a 19.9% market share and import value of $4.7M.

Q: How many temozolomide buyers import from India?

There are 250 active temozolomide buyers importing from India, with a combined import market of $23.5M across 1,261 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top temozolomide buyers from India?

The top 5 temozolomide buyers — YUSEN LOGISTICS BENELUX BELGIUM, TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC, OOO"JODAS EXPOIM", M/S. SUN FARMACEUTICA DO BRAZIL LTD — together control 53.0% of total temozolomide import value from India.

Suresh Sormare

Temozolomide

India Pharmaceutical Trade Intelligence

$23.5M133 Suppliers90 CountriesHS 30049049

ExportsIndia → CANADA31.8%India → BELGIUM22.5%

ImportsBELGIUM → India$34.4K NETHERLANDS → India$30.5K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Market Analysis: Top Importing Countries & Their Importers

1Canada

Canada emerges as the first largest importing country, achieving a total trade value of $7.5M through 38 shipments. This represents a market share of 31.8% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Canada has a diverse importer base, with their top importers including:

• TARO PHARMACEUTICALS INC., - $3.0M (40.7% of country's total business)

• TARO PHARMACEUTICALS INC - $2.7M (36.1% of country's total business)

• TARO PHARMACEUTICALS INC. - $760.9K (10.2% of country's total business)

• JAMP PHARMA CORP - $321.0K (4.3% of country's total business)

Key Insight: Canada demonstrates strong market positioning with an average shipment value of $196.5K, indicating premium pricing strategy compared to the market average of $18.6K.

Canada is a key market for Temozolomide imports, representing 31.8% of total trade value.

Primary Market

Secondary Market

2Belgium

emerges as the second largest importing country, achieving a total trade value of through . This represents a market share of of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Temozolomide buyer market intelligence

1Buyer Segment Analysis

The importation of Temozolomide from India involves various buyer segments, each with distinct purchasing behaviors:

1. Distributors: Entities like Yusen Logistics Benelux Belgium and DEM Pharmaceuticals in Turkey function as intermediaries, procuring large quantities of Temozolomide for distribution to healthcare providers and pharmacies. Their purchasing patterns are characterized by bulk orders to meet the demands of multiple clients.

2. Contract Manufacturers: Companies such as Taro Pharmaceuticals Inc. in Canada and OOO "Jodas Expoim" in Russia likely engage in contract manufacturing. They import Temozolomide to produce finished pharmaceutical products, either for their own brands or on behalf of other companies. Their procurement is typically consistent, aligning with production schedules and client contracts.

3. Re-exporters: Some buyers may act as re-exporters, importing Temozolomide from India to supply other markets. For instance, Yusen Logistics Benelux Belgium's significant import volumes suggest potential redistribution to neighboring European countries. This segment's purchasing behavior is influenced by regional demand fluctuations and trade agreements.

Understanding these segments is crucial for tailoring market strategies, ensuring supply chain efficiency, and meeting the specific needs of each buyer category.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Temozolomide buyer market intelligence

1Country-Specific Import Regulations

Import regulations for Temozolomide vary across the top importing countries:

1. Canada:

Regulatory Authority: Health Canada.

Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure the product has a Notice of Compliance (NOC) and Drug Identification Number (DIN).

Estimated Timeline: The NOC process can take 6-12 months, depending on the submission class and completeness.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are typically duty-free, but importers should verify current rates with the Canada Border Services Agency.

2. Belgium:

Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).

Import Registration Process: Requires a Marketing Authorization (MA) and adherence to EU Good Manufacturing Practices (GMP).

Demand Drivers & Market Opportunity

TransData Nexus Temozolomide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Temozolomide is primarily driven by the prevalence of malignant gliomas, including glioblastoma multiforme and anaplastic astrocytoma. These aggressive brain tumors necessitate effective chemotherapy options, positioning Temozolomide as a critical treatment. The World Health Organization (WHO) includes Temozolomide in its Model List of Essential Medicines, underscoring its importance in global health. (cdn.who.int)

Government healthcare programs and the expansion of universal health coverage in various countries have enhanced access to essential medicines like Temozolomide. Over 150 countries have adopted national essential medicines lists based on the WHO Model List, facilitating procurement and supply. Tender-based purchasing mechanisms, often employed by national health services and international organizations, further streamline the acquisition process, ensuring consistent supply and affordability. (who.int)

With 250 buyers across 90 countries, the global market for Temozolomide reflects a widespread recognition of its therapeutic value and the concerted efforts to make it accessible to patients in need.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Temozolomide Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest temozolomide buyer importing from India?

Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $4.7M in imports and a 19.9% market share — the highest of any single temozolomide importer. TARO PHARMACEUTICALS INC., (CANADA) and TARO PHARMACEUTICALS INC (CANADA) are the next largest buyers.

QHow many companies buy temozolomide from India?

There are 250 active temozolomide buyers importing from India, with a combined market of $23.5M across 1,261 shipments to 90 countries. The top 5 buyers hold 53.0% of total import value, while the remaining 245 buyers handle the other 47.0%.

QWhich countries import the most temozolomide from India?

The top importing countries for temozolomide from India are Canada (31.8%), Belgium (22.5%), Brazil (10.7%), Russia (7.1%), United States (4.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of temozolomide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for temozolomide from India?

The average import transaction value for temozolomide from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Temozolomide buyer market intelligence

1Buyer Segment Analysis

The importation of Temozolomide from India involves various buyer segments, each with distinct purchasing behaviors:

Understanding these segments is crucial for tailoring market strategies, ensuring supply chain efficiency, and meeting the specific needs of each buyer category.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Temozolomide buyer market intelligence

1Country-Specific Import Regulations

Import regulations for Temozolomide vary across the top importing countries:

1. Canada:

Regulatory Authority: Health Canada.

Import Registration Process: Importers must obtain a Drug Establishment License (DEL) and ensure the product has a Notice of Compliance (NOC) and Drug Identification Number (DIN).

Estimated Timeline: The NOC process can take 6-12 months, depending on the submission class and completeness.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are typically duty-free, but importers should verify current rates with the Canada Border Services Agency.

2. Belgium:

Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).

Import Registration Process: Requires a Marketing Authorization (MA) and adherence to EU Good Manufacturing Practices (GMP).

Demand Drivers & Market Opportunity

TransData Nexus Temozolomide buyer market intelligence

1Demand Drivers & Market Opportunity

With 250 buyers across 90 countries, the global market for Temozolomide reflects a widespread recognition of its therapeutic value and the concerted efforts to make it accessible to patients in need.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Temozolomide

Temozolomide

Who Buys Temozolomide from India — 250 Importers Behind a $23.5M Market

Top Temozolomide Importers — Ranked by Import Value

Top Temozolomide Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Temozolomide — and from which countries?

Temozolomide — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Canada

2Belgium

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Temozolomide Buyers & Importers

QWho is the largest temozolomide buyer importing from India?

QHow many companies buy temozolomide from India?

QWhich countries import the most temozolomide from India?

QWhat is the average import order value for temozolomide from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Brazil

4Russia

5United States

Analysis Methodology